IFNA1 and hepatitis C virus infection: Thus, the RR pattern is usually observed in hepatitis C. According to previous studies, about 9.2% to 70% of patients with hepatitis C could develop anti-RR antibodies after antiviral treatment with IFN or RBV (32–34), and the titer of the RR pattern would be gradually decreased and even lost with the end of treatment (35).